An Overview of Dysfibrinogenemia
Clinics in Laboratory Medicine · 2026-06 · 46 (2) · 199-211
DOI: 10.1016/j.cll.2026.02.015 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinics in Laboratory Medicine, 2026-06. Verfasst von Christine Fuja und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Laboratory and Genomic Medicine, Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA; Dep…. Hauptthemen laut MEDLINE: Afibrinogenemia. Die Arbeit nennt 54 Literaturangaben.
Abstract (Originalsprache)
Dysfibrinogenemia is characterized by impaired fibrinogen function and requires specialized laboratory tests for diagnosis. The clinical presentation is highly heterogenous, and dysfibrinogenemia is not a common cause of thrombosis or bleeding. It can be congenital or acquired, and management is highly dependent on dysfibrinogenemia phenotype and clinical context.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Laboratory and Genomic Medicine, Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA; Department of Pathology and Laboratory Medicine, University of Wisconsin…
- Division of Laboratory and Genomic Medicine, Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA.
Zitieren
APA
Fuja, C., & Eby, C. (2026). An Overview of Dysfibrinogenemia. Clinics in Laboratory Medicine, 46(2), 199-211. https://doi.org/10.1016/j.cll.2026.02.015
Vancouver
Fuja C, Eby C. An Overview of Dysfibrinogenemia. Clinics in Laboratory Medicine. 2026;46(2):199-211. doi:10.1016/j.cll.2026.02.015
BibTeX
@article{Fuja2026,
author = {Fuja, Christine and Eby, Charles},
title = {An Overview of Dysfibrinogenemia},
journal = {Clinics in Laboratory Medicine},
year = {2026},
volume = {46},
number = {2},
pages = {199--211},
doi = {10.1016/j.cll.2026.02.015}
}
EUVIMED